+
Open data
-
Basic information
| Entry | Database: PDB / ID: 8vys | ||||||
|---|---|---|---|---|---|---|---|
| Title | Cryo-EM Structure of the BRAF V600E monomer bound to PLX8394 | ||||||
Components |
| ||||||
Keywords | TRANSFERASE/INHIBITOR / BRAF Kinase Monomer Mutant Inhibitor / TRANSFERASE-INHIBITOR complex | ||||||
| Function / homology | Function and homology informationsynaptic target recognition / Golgi reassembly / CD4-positive, alpha-beta T cell differentiation / NOTCH4 Activation and Transmission of Signal to the Nucleus / positive regulation of axon regeneration / myeloid progenitor cell differentiation / respiratory system process / CD4-positive or CD8-positive, alpha-beta T cell lineage commitment / negative regulation of synaptic vesicle exocytosis / establishment of Golgi localization ...synaptic target recognition / Golgi reassembly / CD4-positive, alpha-beta T cell differentiation / NOTCH4 Activation and Transmission of Signal to the Nucleus / positive regulation of axon regeneration / myeloid progenitor cell differentiation / respiratory system process / CD4-positive or CD8-positive, alpha-beta T cell lineage commitment / negative regulation of synaptic vesicle exocytosis / establishment of Golgi localization / tube formation / Signalling to p38 via RIT and RIN / head morphogenesis / endothelial cell apoptotic process / ARMS-mediated activation / negative regulation of fibroblast migration / SHOC2 M1731 mutant abolishes MRAS complex function / Gain-of-function MRAS complexes activate RAF signaling / regulation of synapse maturation / Rap1 signalling / positive regulation of D-glucose transmembrane transport / establishment of protein localization to membrane / positive regulation of axonogenesis / regulation of T cell differentiation / negative regulation of protein localization to nucleus / face development / KSRP (KHSRP) binds and destabilizes mRNA / somatic stem cell population maintenance / thyroid gland development / Negative feedback regulation of MAPK pathway / GP1b-IX-V activation signalling / Frs2-mediated activation / stress fiber assembly / MAP kinase kinase activity / Regulation of localization of FOXO transcription factors / Interleukin-3, Interleukin-5 and GM-CSF signaling / lung development / synaptic vesicle exocytosis / positive regulation of peptidyl-serine phosphorylation / phosphoserine residue binding / Activation of BAD and translocation to mitochondria / negative regulation of endothelial cell apoptotic process / MAP kinase kinase kinase activity / ERK1 and ERK2 cascade / centriolar satellite / regulation of ERK1 and ERK2 cascade / SARS-CoV-2 targets host intracellular signalling and regulatory pathways / thymus development / postsynaptic modulation of chemical synaptic transmission / cellular response to glucose starvation / Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex / SARS-CoV-1 targets host intracellular signalling and regulatory pathways / positive regulation of stress fiber assembly / RHO GTPases activate PKNs / substrate adhesion-dependent cell spreading / positive regulation of substrate adhesion-dependent cell spreading / negative regulation of TORC1 signaling / Transcriptional and post-translational regulation of MITF-M expression and activity / animal organ morphogenesis / cellular response to calcium ion / negative regulation of innate immune response / hippocampal mossy fiber to CA3 synapse / TP53 Regulates Metabolic Genes / Translocation of SLC2A4 (GLUT4) to the plasma membrane / sperm end piece / sperm principal piece / cellular response to xenobiotic stimulus / regulation of protein stability / protein sequestering activity / Deactivation of the beta-catenin transactivating complex / visual learning / RAF activation / Signaling by high-kinase activity BRAF mutants / Spry regulation of FGF signaling / MAP2K and MAPK activation / Negative regulation of NOTCH4 signaling / long-term synaptic potentiation / epidermal growth factor receptor signaling pathway / T cell differentiation in thymus / intracellular protein localization / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / MAPK cascade / Negative regulation of MAPK pathway / melanosome / Signaling by BRAF and RAF1 fusions / regulation of cell population proliferation / T cell receptor signaling pathway / sperm midpiece / presynapse / angiogenesis / cell body / scaffold protein binding / cilium / protein phosphatase binding / blood microparticle / negative regulation of neuron apoptotic process / DNA-binding transcription factor binding Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 3.06 Å | ||||||
Authors | Lavoie, H. / Lajoie, D. / Jin, T. / Decossas, M. / Maisonneuve, P. / Therrien, M. | ||||||
| Funding support | Canada, 1items
| ||||||
Citation | Journal: Science / Year: 2025Title: BRAF oncogenic mutants evade autoinhibition through a common mechanism. Authors: Hugo Lavoie / Ting Jin / Driss Lajoie / Marion Decossas / Patrick Gendron / Bing Wang / Frantisek Filandr / Malha Sahmi / Chang Hwa Jo / Sandra Weber / Geneviève Arseneault / Sasmita ...Authors: Hugo Lavoie / Ting Jin / Driss Lajoie / Marion Decossas / Patrick Gendron / Bing Wang / Frantisek Filandr / Malha Sahmi / Chang Hwa Jo / Sandra Weber / Geneviève Arseneault / Sasmita Tripathy / Pierre Beaulieu / Doris A Schuetz / David C Schriemer / Anne Marinier / William J Rice / Pierre Maisonneuve / Marc Therrien / ![]() Abstract: Uncontrolled activation of the rat sarcoma (RAS)-extracellular signal-regulated kinase (ERK) pathway drives tumor growth, often because of oncogenic BRAF mutations. BRAF regulation, involving ...Uncontrolled activation of the rat sarcoma (RAS)-extracellular signal-regulated kinase (ERK) pathway drives tumor growth, often because of oncogenic BRAF mutations. BRAF regulation, involving monomeric autoinhibition and activation by dimerization, has been intensely scrutinized, but mechanisms enabling oncogenic mutants to evade regulation remain unclear. By using cryo-electron microscopy, we solved the three-dimensional structures of the three oncogenic BRAF mutant classes, including the common V600E variant. These mutations disrupted wild-type BRAF's autoinhibited state, mediated by interactions between the cysteine-rich domain and kinase domain, thereby shifting the kinase domain into a preactivated conformation. This structural change likely results from helix αC displacement. PLX8394, a BRAF inhibitor that stabilizes helix αC in an inactive conformation, restored the autoinhibited conformation of oncogenic BRAF, explaining the properties of this class of compounds. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 8vys.cif.gz | 275.4 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb8vys.ent.gz | Display | PDB format | |
| PDBx/mmJSON format | 8vys.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/vy/8vys ftp://data.pdbj.org/pub/pdb/validation_reports/vy/8vys | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 43677MC ![]() 8vyoC ![]() 8vypC ![]() 8vyqC ![]() 8vyrC ![]() 8vyuC ![]() 8vyvC ![]() 8vywC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
| #1: Protein | Mass: 84800.750 Da / Num. of mol.: 1 / Mutation: V600E Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Cell: FreeStyle 293-F cells / Gene: BRAF, BRAF1, RAFB1 / Plasmid: pCDNA3.1-FLAG-TEV-BRAF V600E / Cell (production host): FreeStyle 293-F cells / Production host: Homo sapiens (human)References: UniProt: P15056, non-specific serine/threonine protein kinase | ||||||
|---|---|---|---|---|---|---|---|
| #2: Protein | Mass: 27645.895 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) Homo sapiens (human) / Cell line: FreeStyle 293-F cells / References: UniProt: P63104#3: Chemical | ChemComp-A1AEN / ( | Mass: 542.533 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C25H21F3N6O3S / Feature type: SUBJECT OF INVESTIGATION Has ligand of interest | Y | Has protein modification | Y | |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: BRAF V600E - 14.3.3 complex bound to PLX8394 / Type: COMPLEX Details: BRAF complex purified by Flag affinity purification followed by TEV elution from FreeStyle 293F cells Entity ID: #1-#2 / Source: MULTIPLE SOURCES | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular weight | Value: 0.141 MDa / Experimental value: NO | ||||||||||||||||||||||||||||||
| Source (natural) | Organism: Homo sapiens (human) | ||||||||||||||||||||||||||||||
| Source (recombinant) | Organism: Homo sapiens (human) / Cell: FreeStyle 293-F cells / Plasmid: pCDNA3.1-FLAG-TEV-BRAF V600E | ||||||||||||||||||||||||||||||
| Buffer solution | pH: 7.5 | ||||||||||||||||||||||||||||||
| Buffer component |
| ||||||||||||||||||||||||||||||
| Specimen | Conc.: 1 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES | ||||||||||||||||||||||||||||||
| Vitrification | Cryogen name: ETHANE / Humidity: 80 % / Details: Chameleon system (SPT Labtech) |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: FLOOD BEAM |
| Electron lens | Mode: BRIGHT FIELD / Nominal defocus max: 1500 nm / Nominal defocus min: 1300 nm |
| Image recording | Electron dose: 56.44 e/Å2 / Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) |
-
Processing
| EM software |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 3.06 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 177000 Details: Resolution corresponds to the FSC 0.143 cut-off of the masked map. Symmetry type: POINT | ||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi




Homo sapiens (human)
Canada, 1items
Citation
















PDBj











FIELD EMISSION GUN